Answers are grounded in this paper and cite their sources.
Compares activated partial thromboplastin time against direct assays for monitoring lepirudin in heparin-induced thrombocytopenia, highlighting alternatives to standard testing.
Lepirudin (r-hirudin) is one of the two alternative anticoagulants licensed to treat patients with heparin-induced thrombocytopenia (HIT). Manufacturer's guidelines state that lepirudin should be monitored using the activated partial thromboplastin time (APTT) ratio. However, several studies have demonstrated a plateau effect of higher concentrations of lepirudin on APTT ratios and variable results when comparing different APTT reagents. This study compares APTT ratios (using two different APTT reagents) with two other commercially available methods for directly quantifying plasma lepirudin levels: ecarin chromogenic assay and prothrombinase-induced clotting time in 95 samples from five patients receiving lepirudin anticoagulation for HIT.
No takes yet. Share an insight, caveat, or question.
Guy et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: